XML 85 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Investments in and Advances to Joint Ventures - Summary of Financial Information for Consolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 1,586,571   $ 1,586,571   $ 1,843,130
Total assets 3,823,933   3,823,933   3,937,704
Current liabilities 1,060,659   1,060,659   1,187,409
Total liabilities 1,970,057   1,970,057   2,076,287
Total joint venture equity 1,824,078   1,824,078   1,813,772
Revenue 956,050 $ 1,004,236 2,710,103 $ 2,954,688  
Costs 734,652 788,769 2,084,062 2,307,725  
Net income attributable to Parsons Corporation 19,358 40,658 35,099 76,930  
Net income attributable to noncontrolling interests 7,411 5,862 17,711 15,086  
Consolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 253,105   253,105   292,407
Noncurrent assets 1,856   1,856   2,990
Total assets 254,961   254,961   295,397
Current liabilities 194,543   194,543   201,270
Total liabilities 194,543   194,543   201,270
Total joint venture equity 60,418   60,418   $ 94,127
Revenue 101,816 117,344 296,685 335,511  
Costs 86,726 105,223 260,129 304,308  
Net income attributable to Parsons Corporation 15,090 12,121 36,556 31,203  
Net income attributable to noncontrolling interests $ 7,411 $ 5,862 $ 17,711 $ 15,086